Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3696908017 | Medroxyprogesterone acetate 150 mg/mL suspension for injection syringe | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3696909013 | Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection syringe (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4142321000052116 | medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Has basis of strength substance (attribute) | Medroxyprogesterone acetate | false | Inferred relationship | Some | 1 | |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | har täljarvärde för koncentrationsstyrka | 150 | false | Inferred relationship | Some | 1 | |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Has manufactured dose form | Suspension for injection | false | Inferred relationship | Some | ||
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Has precise active ingredient | Medroxyprogesterone acetate | false | Inferred relationship | Some | 1 | |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Has concentration strength denominator unit | mL | false | Inferred relationship | Some | 1 | |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Has concentration strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Has presentation strength denominator unit (attribute) | mL | false | Inferred relationship | Some | 1 | |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | har täljarvärde som visar styrka | 150 | false | Inferred relationship | Some | 1 | |
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Has unit of presentation | Syringe | false | Inferred relationship | Some | ||
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Is a | Medroxyprogesterone-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Is a | progestinpreparat | false | Inferred relationship | Some | ||
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, spruta | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR